The University of Chicago Header Logo

Connection

Jason X. Cheng to Treatment Outcome

This is a "connection" page, showing publications Jason X. Cheng has written about Treatment Outcome.
Connection Strength

0.258
  1. Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment. Eur J Surg Oncol. 2019 Aug; 45(8):1498-1504.
    View in: PubMed
    Score: 0.067
  2. Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy. Oncotarget. 2016 Jul 12; 7(28):44224-44235.
    View in: PubMed
    Score: 0.056
  3. Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma. Chronobiol Int. 2016; 33(2):210-9.
    View in: PubMed
    Score: 0.054
  4. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study. J Surg Oncol. 2008 Jul 01; 98(1):34-41.
    View in: PubMed
    Score: 0.032
  5. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.024
  6. Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience. Oncology. 2024; 102(11):913-923.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.